The research was conducted by CDC and Premier, a performance improvement company. Researchers conducted a retrospective analysis of inpatient pharmacy data from more than 500 U.S. hospitals. The analysis showed that 78 percent of hospitals had evidence of potentially unnecessary antibiotic combinations being administered for two or more days, with a total of 32,507 cases of redundant antibiotics treatment.
The study found that these cases represented 148,589 days of potentially inappropriate antibiotic therapy, resulting in nearly $13 million in potentially avoidable healthcare costs from antimicrobial drugs. If these cases were representative of all U.S. hospitals over the same time period, an estimated $163 million could have been saved through appropriate prescribing.
“Improving the way antibiotics are prescribed not only helps reduce rates of Clostridium difficile infection and antibiotic resistance, but can also improve individual patient outcomes, all while reducing healthcare costs,” said Arjun Srinivasan, MD, associate director for Healthcare Associated Infection Prevention Programs in the Division of Healthcare Quality Promotion at CDC and a study author.
More articles on quality:
Top 10 infection control stories, September 1-5
Antibiotic stewardship programs reduce hospital costs, improve outcomes
Children’s HAI rates plummet
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
